Global Esketamine Hydrochloride Injection Market Growth 2026-2032

February 2026 | 82 pages | ID: G5544134C87CEN
LP Information

Abstracts

The global Esketamine Hydrochloride Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Esketamine Injection is is an intravenous anesthetic, sold under the brand names Ketanest among others, is the S(+) enantiomer of ketamine. It is a dissociative hallucinogen drug used as a general anesthetic. Esketamine is the active enantiomer of ketamine in terms of NMDA receptor antagonism and is more potent than racemic ketamine.

United States market for Esketamine Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Esketamine Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Esketamine Hydrochloride Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Esketamine Hydrochloride Injection players cover Pfizer, Laboratoires CDM Lavoisier, Jiangsu Hengrui Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Esketamine Hydrochloride Injection Industry Forecast” looks at past sales and reviews total world Esketamine Hydrochloride Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Esketamine Hydrochloride Injection sales for 2026 through 2032. With Esketamine Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Esketamine Hydrochloride Injection industry.

This Insight Report provides a comprehensive analysis of the global Esketamine Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Esketamine Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Esketamine Hydrochloride Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Esketamine Hydrochloride Injection and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Esketamine Hydrochloride Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Esketamine Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Specification:

• 2ml:50mg
• 5ml:25mg
• Others

Segmentation by Application:

• Hospitals and Clinics
• Ambulatory Surgery Centers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Laboratoires CDM Lavoisier
• Jiangsu Hengrui Medicine

Key Questions Addressed in this Report

What is the 10-year outlook for the global Esketamine Hydrochloride Injection market?

What factors are driving Esketamine Hydrochloride Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Esketamine Hydrochloride Injection market opportunities vary by end market size?

How does Esketamine Hydrochloride Injection break out by Specification, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Esketamine Hydrochloride Injection Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Esketamine Hydrochloride Injection by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Esketamine Hydrochloride Injection by Country/Region, 2021, 2025 & 2032
2.2 Esketamine Hydrochloride Injection Segment by Specification
  2.2.1 2ml:50mg
  2.2.2 5ml:25mg
  2.2.3 Others
  2.2.4 Esketamine Hydrochloride Injection Sales by Specification
    2.2.4.1 Global Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
    2.2.4.2 Global Esketamine Hydrochloride Injection Revenue and Market Share by Specification (2021-2026)
    2.2.4.3 Global Esketamine Hydrochloride Injection Sale Price by Specification (2021-2026)
2.3 Esketamine Hydrochloride Injection Segment by Application
  2.3.1 Hospitals and Clinics
  2.3.2 Ambulatory Surgery Centers
  2.3.3 Esketamine Hydrochloride Injection Sales by Application
    2.3.3.1 Global Esketamine Hydrochloride Injection Sale Market Share by Application (2021-2026)
    2.3.3.2 Global Esketamine Hydrochloride Injection Revenue and Market Share by Application (2021-2026)
    2.3.3.3 Global Esketamine Hydrochloride Injection Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Esketamine Hydrochloride Injection Breakdown Data by Company
  3.1.1 Global Esketamine Hydrochloride Injection Annual Sales by Company (2021-2026)
  3.1.2 Global Esketamine Hydrochloride Injection Sales Market Share by Company (2021-2026)
3.2 Global Esketamine Hydrochloride Injection Annual Revenue by Company (2021-2026)
  3.2.1 Global Esketamine Hydrochloride Injection Revenue by Company (2021-2026)
  3.2.2 Global Esketamine Hydrochloride Injection Revenue Market Share by Company (2021-2026)
3.3 Global Esketamine Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Esketamine Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Esketamine Hydrochloride Injection Product Location Distribution
  3.4.2 Players Esketamine Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ESKETAMINE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Esketamine Hydrochloride Injection Market Size by Geographic Region (2021-2026)
  4.1.1 Global Esketamine Hydrochloride Injection Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Esketamine Hydrochloride Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Esketamine Hydrochloride Injection Market Size by Country/Region (2021-2026)
  4.2.1 Global Esketamine Hydrochloride Injection Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Esketamine Hydrochloride Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Esketamine Hydrochloride Injection Sales Growth
4.4 APAC Esketamine Hydrochloride Injection Sales Growth
4.5 Europe Esketamine Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Esketamine Hydrochloride Injection Sales Growth

5 AMERICAS

5.1 Americas Esketamine Hydrochloride Injection Sales by Country
  5.1.1 Americas Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  5.1.2 Americas Esketamine Hydrochloride Injection Revenue by Country (2021-2026)
5.2 Americas Esketamine Hydrochloride Injection Sales by Specification (2021-2026)
5.3 Americas Esketamine Hydrochloride Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Esketamine Hydrochloride Injection Sales by Region
  6.1.1 APAC Esketamine Hydrochloride Injection Sales by Region (2021-2026)
  6.1.2 APAC Esketamine Hydrochloride Injection Revenue by Region (2021-2026)
6.2 APAC Esketamine Hydrochloride Injection Sales by Specification (2021-2026)
6.3 APAC Esketamine Hydrochloride Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Esketamine Hydrochloride Injection by Country
  7.1.1 Europe Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  7.1.2 Europe Esketamine Hydrochloride Injection Revenue by Country (2021-2026)
7.2 Europe Esketamine Hydrochloride Injection Sales by Specification (2021-2026)
7.3 Europe Esketamine Hydrochloride Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Esketamine Hydrochloride Injection by Country
  8.1.1 Middle East & Africa Esketamine Hydrochloride Injection Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Esketamine Hydrochloride Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Esketamine Hydrochloride Injection Sales by Specification (2021-2026)
8.3 Middle East & Africa Esketamine Hydrochloride Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Esketamine Hydrochloride Injection
10.3 Manufacturing Process Analysis of Esketamine Hydrochloride Injection
10.4 Industry Chain Structure of Esketamine Hydrochloride Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Esketamine Hydrochloride Injection Distributors
11.3 Esketamine Hydrochloride Injection Customer

12 WORLD FORECAST REVIEW FOR ESKETAMINE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION

12.1 Global Esketamine Hydrochloride Injection Market Size Forecast by Region
  12.1.1 Global Esketamine Hydrochloride Injection Forecast by Region (2027-2032)
  12.1.2 Global Esketamine Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Esketamine Hydrochloride Injection Forecast by Specification (2027-2032)
12.7 Global Esketamine Hydrochloride Injection Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Esketamine Hydrochloride Injection Product Portfolios and Specifications
  13.1.3 Pfizer Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 Laboratoires CDM Lavoisier
  13.2.1 Laboratoires CDM Lavoisier Company Information
  13.2.2 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolios and Specifications
  13.2.3 Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Laboratoires CDM Lavoisier Main Business Overview
  13.2.5 Laboratoires CDM Lavoisier Latest Developments
13.3 Jiangsu Hengrui Medicine
  13.3.1 Jiangsu Hengrui Medicine Company Information
  13.3.2 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolios and Specifications
  13.3.3 Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Jiangsu Hengrui Medicine Main Business Overview
  13.3.5 Jiangsu Hengrui Medicine Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Esketamine Hydrochloride Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Esketamine Hydrochloride Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2ml:50mg
Table 4. Major Players of 5ml:25mg
Table 5. Major Players of Others
Table 6. Global Esketamine Hydrochloride Injection Sales by Specification (2021-2026) & (K Units)
Table 7. Global Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
Table 8. Global Esketamine Hydrochloride Injection Revenue by Specification (2021-2026) & ($ million)
Table 9. Global Esketamine Hydrochloride Injection Revenue Market Share by Specification (2021-2026)
Table 10. Global Esketamine Hydrochloride Injection Sale Price by Specification (2021-2026) & (US$/Unit)
Table 11. Global Esketamine Hydrochloride Injection Sale by Application (2021-2026) & (K Units)
Table 12. Global Esketamine Hydrochloride Injection Sale Market Share by Application (2021-2026)
Table 13. Global Esketamine Hydrochloride Injection Revenue by Application (2021-2026) & ($ million)
Table 14. Global Esketamine Hydrochloride Injection Revenue Market Share by Application (2021-2026)
Table 15. Global Esketamine Hydrochloride Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Esketamine Hydrochloride Injection Sales by Company (2021-2026) & (K Units)
Table 17. Global Esketamine Hydrochloride Injection Sales Market Share by Company (2021-2026)
Table 18. Global Esketamine Hydrochloride Injection Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Esketamine Hydrochloride Injection Revenue Market Share by Company (2021-2026)
Table 20. Global Esketamine Hydrochloride Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Esketamine Hydrochloride Injection Producing Area Distribution and Sales Area
Table 22. Players Esketamine Hydrochloride Injection Products Offered
Table 23. Esketamine Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Esketamine Hydrochloride Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Esketamine Hydrochloride Injection Sales Market Share Geographic Region (2021-2026)
Table 28. Global Esketamine Hydrochloride Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Esketamine Hydrochloride Injection Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Esketamine Hydrochloride Injection Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Esketamine Hydrochloride Injection Sales Market Share by Country/Region (2021-2026)
Table 32. Global Esketamine Hydrochloride Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Esketamine Hydrochloride Injection Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 35. Americas Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026)
Table 36. Americas Esketamine Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Esketamine Hydrochloride Injection Sales by Specification (2021-2026) & (K Units)
Table 38. Americas Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 39. APAC Esketamine Hydrochloride Injection Sales by Region (2021-2026) & (K Units)
Table 40. APAC Esketamine Hydrochloride Injection Sales Market Share by Region (2021-2026)
Table 41. APAC Esketamine Hydrochloride Injection Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Esketamine Hydrochloride Injection Sales by Specification (2021-2026) & (K Units)
Table 43. APAC Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 44. Europe Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 45. Europe Esketamine Hydrochloride Injection Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Esketamine Hydrochloride Injection Sales by Specification (2021-2026) & (K Units)
Table 47. Europe Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Esketamine Hydrochloride Injection Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Esketamine Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Esketamine Hydrochloride Injection Sales by Specification (2021-2026) & (K Units)
Table 51. Middle East & Africa Esketamine Hydrochloride Injection Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Esketamine Hydrochloride Injection
Table 53. Key Market Challenges & Risks of Esketamine Hydrochloride Injection
Table 54. Key Industry Trends of Esketamine Hydrochloride Injection
Table 55. Esketamine Hydrochloride Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Esketamine Hydrochloride Injection Distributors List
Table 58. Esketamine Hydrochloride Injection Customer List
Table 59. Global Esketamine Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Esketamine Hydrochloride Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Esketamine Hydrochloride Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Esketamine Hydrochloride Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Esketamine Hydrochloride Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Esketamine Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Esketamine Hydrochloride Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Esketamine Hydrochloride Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Esketamine Hydrochloride Injection Sales Forecast by Specification (2027-2032) & (K Units)
Table 70. Global Esketamine Hydrochloride Injection Revenue Forecast by Specification (2027-2032) & ($ millions)
Table 71. Global Esketamine Hydrochloride Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Esketamine Hydrochloride Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Pfizer Basic Information, Esketamine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Esketamine Hydrochloride Injection Product Portfolios and Specifications
Table 75. Pfizer Esketamine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Laboratoires CDM Lavoisier Basic Information, Esketamine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Product Portfolios and Specifications
Table 80. Laboratoires CDM Lavoisier Esketamine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Laboratoires CDM Lavoisier Main Business
Table 82. Laboratoires CDM Lavoisier Latest Developments
Table 83. Jiangsu Hengrui Medicine Basic Information, Esketamine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Product Portfolios and Specifications
Table 85. Jiangsu Hengrui Medicine Esketamine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Jiangsu Hengrui Medicine Main Business
Table 87. Jiangsu Hengrui Medicine Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Esketamine Hydrochloride Injection
Figure 2. Esketamine Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Esketamine Hydrochloride Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Esketamine Hydrochloride Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Esketamine Hydrochloride Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Esketamine Hydrochloride Injection Sales Market Share by Country/Region (2025)
Figure 10. Esketamine Hydrochloride Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2ml:50mg
Figure 12. Product Picture of 5ml:25mg
Figure 13. Product Picture of Others
Figure 14. Global Esketamine Hydrochloride Injection Sales Market Share by Specification in 2026
Figure 15. Global Esketamine Hydrochloride Injection Revenue Market Share by Specification (2021-2026)
Figure 16. Esketamine Hydrochloride Injection Consumed in Hospitals and Clinics
Figure 17. Global Esketamine Hydrochloride Injection Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 18. Esketamine Hydrochloride Injection Consumed in Ambulatory Surgery Centers
Figure 19. Global Esketamine Hydrochloride Injection Market: Ambulatory Surgery Centers (2021-2026) & (K Units)
Figure 20. Global Esketamine Hydrochloride Injection Sale Market Share by Application (2025)
Figure 21. Global Esketamine Hydrochloride Injection Revenue Market Share by Application in 2026
Figure 22. Esketamine Hydrochloride Injection Sales by Company in 2026 (K Units)
Figure 23. Global Esketamine Hydrochloride Injection Sales Market Share by Company in 2026
Figure 24. Esketamine Hydrochloride Injection Revenue by Company in 2026 ($ millions)
Figure 25. Global Esketamine Hydrochloride Injection Revenue Market Share by Company in 2026
Figure 26. Global Esketamine Hydrochloride Injection Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Esketamine Hydrochloride Injection Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Esketamine Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 29. Americas Esketamine Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 30. APAC Esketamine Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 31. APAC Esketamine Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 32. Europe Esketamine Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 33. Europe Esketamine Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Esketamine Hydrochloride Injection Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Esketamine Hydrochloride Injection Revenue 2021-2026 ($ millions)
Figure 36. Americas Esketamine Hydrochloride Injection Sales Market Share by Country in 2026
Figure 37. Americas Esketamine Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 38. Americas Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
Figure 39. Americas Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 40. United States Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Esketamine Hydrochloride Injection Sales Market Share by Region in 2026
Figure 45. APAC Esketamine Hydrochloride Injection Revenue Market Share by Region (2021-2026)
Figure 46. APAC Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
Figure 47. APAC Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 48. China Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. India Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Esketamine Hydrochloride Injection Sales Market Share by Country in 2026
Figure 56. Europe Esketamine Hydrochloride Injection Revenue Market Share by Country (2021-2026)
Figure 57. Europe Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
Figure 58. Europe Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 59. Germany Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. France Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Esketamine Hydrochloride Injection Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Esketamine Hydrochloride Injection Sales Market Share by Specification (2021-2026)
Figure 66. Middle East & Africa Esketamine Hydrochloride Injection Sales Market Share by Application (2021-2026)
Figure 67. Egypt Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Esketamine Hydrochloride Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Esketamine Hydrochloride Injection in 2026
Figure 73. Manufacturing Process Analysis of Esketamine Hydrochloride Injection
Figure 74. Industry Chain Structure of Esketamine Hydrochloride Injection
Figure 75. Channels of Distribution
Figure 76. Global Esketamine Hydrochloride Injection Sales Market Forecast by Region (2027-2032)
Figure 77. Global Esketamine Hydrochloride Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Esketamine Hydrochloride Injection Sales Market Share Forecast by Specification (2027-2032)
Figure 79. Global Esketamine Hydrochloride Injection Revenue Market Share Forecast by Specification (2027-2032)
Figure 80. Global Esketamine Hydrochloride Injection Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Esketamine Hydrochloride Injection Revenue Market Share Forecast by Application (2027-2032)